Completed
Measuring cognitive decline in patients at high risk for developing HIV-related neurocognitive dysfunction
Learn MoreCompleted
Clindamycin, Primaquine vs.Trimethoprim Sulphamethoxazole
Learn MoreCompleted
Effects of HLA allele frequencies on HIV disease progression and viral load among newly diagnosed HIV infected individuals in Manitoba: Trial Results
Learn MoreReporting
Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir
Learn MoreCompleted
Double Blind Comparison of ddI and Continued Zidovudine (AZT) in Therapy of Patients with HIV-Related Immune Suppression: Trial results
Learn MoreReporting
SPOT, a rapid HIV testing intervention for MSM: measuring the impact of counselling on sexual risk behaviours
Learn MoreCompleted
A case-control study of novel bone imaging techniques and plasma markers in HIV-infected persons with or without fragility fractures
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
